The Latest Cardiac and Vascular News
LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech […]
Topline data expected in the second half of 2021 ST. GALLEN, Switzerland & UNIONDALE, NY–(BUSINESS WIRE)–Regulatory News: Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN), today announced completion of enrollment for Angion’s AKI-002-15 study, a phase-II trial of ANG-3777 in patients at risk of cardiac-surgery associated acute kidney injury (CSA-AKI). […]
DANVERS, Mass.–(BUSINESS WIRE)–The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used, including placement of an Impella heart pump prior to revascularization (PCI). The study evaluated the outcomes of 406 consecutive patients who presented […]
DUBLIN, April 28, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 roll-ins) treated in the OPTIMIZE PRO clinical study. The post-market, prospective, multi-center study is evaluating procedural outcomes (including pacemaker rate) associated with procedure-related […]
OXFORD, England, April 28, 2021 /PRNewswire/ — GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic […]
Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care WASHINGTON, April 28, 2021 /PRNewswire/ — The American College of Cardiology (ACC) and HealthReveal, a leading clinical artificial intelligence company, are collaborating to employ HealthReveal’s personalized clinical AI solution to ACC’s TRANSFORM studies. Through the collaboration, study data […]
Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths globally² Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment Early diagnosis and treatment can contribute to saving or improving people’s lives […]
VANCOUVER and MINNEAPOLIS, April 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced progress towards its value creation strategy of expanding global reimbursement for the Neovasc Reducer™ (“Reducer”). Expanding reimbursement for the Reducer is a key component of Neovasc’s strategy to create shareholder value. In […]
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule SANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the Centers for Medicare and Medicaid […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announced the presentation of the First Report of the GUARDIAN Registry1 at the International Society for Heart and Lung Transplantation 2021 Annual Meeting. The GUARDIAN study is the largest multi-center, international registry specifically focused on donor heart preservation. Clinical investigators from the first five enrolling centers collaborated to pool their data and […]
